Premium
Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H‐ ras transformed cell lines
Author(s) -
Hurta Robert A. R.,
Wright Jim A.
Publication year - 1994
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.1041610224
Subject(s) - cycloheximide , forskolin , ornithine decarboxylase , cholera toxin , ornithine decarboxylase antizyme , cell culture , signal transduction , biology , 12 o tetradecanoylphorbol 13 acetate , microbiology and biotechnology , medicine , endocrinology , protein biosynthesis , enzyme , biochemistry , protein kinase c , phorbol ester , genetics
We have tested the hypothesis that H‐ras transformed cells contain alterations in signal pathways important in controlling the expression of ornithine decarboxylase (ODC), the highly regulated rate‐limiting activity in the biosynthesis polyamines. Mouse 10 T 1/2 fibroblasts and a series of 10 T 1/2 H‐ras transformed cell lines were treated with stimulators of cAMP synthesis (forskolin and cholera toxin), a biologically stable analogue of cAMP (8‐bromo‐cAMP), and an inhibitor of cAMP degradation (3‐isobutyl‐1‐methylxanthine). Elevations in ODC gene expression were noted in H‐ras transformed cells that were not observed in parental 10 T 1/2 fibroblasts. The forskolin‐mediated effects were not detected with 1,9‐dideoxyforskolin, a compound structurally related to forskolin, which does not activate adenyl cyclase. The effects observed with cholera toxin were not detected when cells were treated with the purified subunits of this compound, indicating that the toxin‐induced effects were cAMP‐specific. Actinomycin D treatment prior to forskolin exposure reduced the elevation observed in ODC gene expression indicating the involvement of the transcriptional process. Furthermore, we observed that cycloheximide treatment of malignant but not benign H‐ras transformed cells significantly elevated ODC message level. Treatment of malignant cells with both cycloheximide and forskolin together resulted in a further additive elevation in ODC message, but a similar treatment of benign tumor cells reduced the forskolin‐mediated increase in ODC message. In addition, treatment of H‐ras transformed cell with the tumor promoter, 12‐0‐tetradecanoylphorbol‐13‐acetate (TPA) led to an elevation in ODC mRNA levels not observed in parental 10 T 1/2 fibroblasts. Cells treated with a combination of TPA and forskolin. Exposure of H‐ras transformed cells to TPA and forskolin together led to further pronounced increases in ODC message when compared to treatment with TPA or forskolin alone. These results demonstrate aberrant regulation of signal pathways involved in controlling ODC gene expression in H‐ras transformed cells and provide further insight into the altered growth regulatory program associated with malignant transformation. © 1994 Wiley‐Liss, Inc.